| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 14.49× | 14.49× | 19.46× | 26.46× | 27.39× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.93× | 1.81× | 1.23× | 1.30× | 1.20× | ||
| 0.39× | 0.39× | 0.34× | 0.34× | 0.33× | ||
| 0.95× | 0.95× | 1.08× | 1.42× | 1.18× | ||
| 0.69× | 0.69× | 0.74× | 0.85× | 0.74× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 27.39 | 26.46 | 19.46 | 14.49 | 14.49 | |
| Working Capital Turnover | 1.20 | 1.30 | 1.23 | 1.81 | 1.93 | |
| Asset Turnover | 0.33 | 0.34 | 0.34 | 0.39 | 0.39 | |
| Cash Conversion (CFO/Net Income) | 1.18 | 1.42 | 1.08 | 0.95 | 0.95 | |
| CFO/EBITDA | 0.74 | 0.85 | 0.74 | 0.69 | 0.69 |